Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dendritic Cell Vaccination in Combination With Docetaxel for Patients With Cancer Prostate - a Randomized Phase II Study

NCT01446731 is registered in ClinicalTrials.gov with Inge Marie Svane as lead sponsor.

NCT NCT01446731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01446731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dendritic Cell Vaccination in Combination With Docetaxel for Patients With Cancer Prostate - a Randomized Phase II Study
Lead sponsor
Inge Marie Svane
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2011
Completion date
August 31, 2015
Enrollment
43 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prostatic neoplasms